The weekly litigation news digest is live. Subscribe now

Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd) - EP2909232

The patent EP2909232 was granted to Centre National DE LA Recherche Scientifique Cnrs on Mar 11, 2020. The application was originally filed on Oct 17, 2013 under application number EP13777084A. The patent is currently recorded with a legal status of "Revoked".

EP2909232

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP13777084A
Filing Date
Oct 17, 2013
Status
Revoked
Apr 4, 2025
Publication Date
Mar 11, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREDec 11, 2020MACLEANADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2383286
INTERNATIONAL-SEARCH-REPORTWO02081513
INTERNATIONAL-SEARCH-REPORTWO2005113586
INTERNATIONAL-SEARCH-REPORTWO2013063383
OPPOSITIONEP2383286
OPPOSITIONWO02081513
OPPOSITIONWO2005113586
OPPOSITIONWO2013063383

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents